Cargando…
_version_ 1783646374902890496
author Mendez, Sean R.
Frank, Rachel C.
Stevenson, Elizabeth K.
Chung, Mabel
Silverman, Michael G.
author_facet Mendez, Sean R.
Frank, Rachel C.
Stevenson, Elizabeth K.
Chung, Mabel
Silverman, Michael G.
author_sort Mendez, Sean R.
collection PubMed
description
format Online
Article
Text
id pubmed-7857077
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American College of Chest Physicians. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-78570772021-02-04 Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19 Mendez, Sean R. Frank, Rachel C. Stevenson, Elizabeth K. Chung, Mabel Silverman, Michael G. Chest Chest Infections: Research Letter American College of Chest Physicians. Published by Elsevier Inc. 2021-07 2021-02-03 /pmc/articles/PMC7857077/ /pubmed/33548220 http://dx.doi.org/10.1016/j.chest.2021.01.073 Text en © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Chest Infections: Research Letter
Mendez, Sean R.
Frank, Rachel C.
Stevenson, Elizabeth K.
Chung, Mabel
Silverman, Michael G.
Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
title Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
title_full Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
title_fullStr Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
title_full_unstemmed Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
title_short Dihydropyridine Calcium Channel Blockers and the Risk of Severe COVID-19
title_sort dihydropyridine calcium channel blockers and the risk of severe covid-19
topic Chest Infections: Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857077/
https://www.ncbi.nlm.nih.gov/pubmed/33548220
http://dx.doi.org/10.1016/j.chest.2021.01.073
work_keys_str_mv AT mendezseanr dihydropyridinecalciumchannelblockersandtheriskofseverecovid19
AT frankrachelc dihydropyridinecalciumchannelblockersandtheriskofseverecovid19
AT stevensonelizabethk dihydropyridinecalciumchannelblockersandtheriskofseverecovid19
AT chungmabel dihydropyridinecalciumchannelblockersandtheriskofseverecovid19
AT silvermanmichaelg dihydropyridinecalciumchannelblockersandtheriskofseverecovid19